文献速递自身炎症与 IgG4 相关病

TNFRSF1A嵌合变异:肿瘤坏死因子受体相关周期性综合征的新兴病因

Mosaic variants in TNFRSF1A: an emerging cause of tumour necrosis factor receptor-associated periodic syndrome.
PubMed 文献 · Rheumatology (Oxford) · 2022-01-01

本文报告一名36岁男性患者反复发热12年,高深度NGS检出TNFRSF1A嵌合变异c.176G>A p.(Cys59Tyr),Sanger测序未能发现,全血变异等位基因分数为14%,累及髓系与淋系。结合既往3例TNFRSF1A嵌合变异报告,作者提出嵌合变异可位于CRD1域,并强调高深度NGS对避免TRAPS误诊的必要性及遗传咨询需考虑生殖细胞嵌合。

要点

  • 高深度NGS可检测Sanger测序漏检的TNFRSF1A嵌合变异,避免TRAPS误诊。
  • 本病例嵌合变异p.(Cys59Tyr)位于CRD1域,全血变异等位基因分数14%,累及髓系与淋系。
  • 既往报告的3例TNFRSF1A嵌合变异均位于CRD2域,且可累及生殖细胞。

核心结论

  • 本研究将TNFRSF1A嵌合变异的定位扩展至CRD1域;胚系突变热点所涉及的残基也可参与合子后突变事件。

研究设计与样本

  • 对一名36岁、反复发热12年的男性患者进行SAID基因panel高深度NGS检测、外周血亚群变异等位基因分布分析、基于TNFRSF1A晶体结构的嵌合变异计算机分析,并回顾既往报道的极罕见TNFRSF1A嵌合变异。

主要发现

  • 高深度NGS检出TNFRSF1A嵌合变异c.176G>A p.(Cys59Tyr),Sanger测序未能检出,全血变异等位基因分数为14%,累及髓系与淋系。
  • p.(Cys59Tyr)为复发性胚系致病性变异,累及位于第一半胱氨酸富集域(CRD1)并参与二硫键的关键半胱氨酸,该位点引入酪氨酸预期会破坏CRD1结构。
  • 回顾既往3例TNFRSF1A嵌合变异,均位于CRD2的小区域,且生殖细胞可受累。
  • 包括本研究在内,迄今仅报告4例TNFRSF1A嵌合变异患者。

临床怎么用

  • 作者强调需采用高深度NGS方法以避免TRAPS的误诊。
  • 作者指出遗传咨询必须考虑生殖细胞中可能出现TNFRSF1A嵌合变异。

局限性

  • 包括本研究在内,迄今仅报告4例TNFRSF1A嵌合变异患者。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: To identify the molecular basis of a systemic autoinflammatory disorder (SAID) evocative of TNF receptor-associated periodic syndrome (TRAPS). METHODS: (i) Deep next generation sequencing (NGS) through a SAID gene panel; (ii) variant allele distribution in peripheral blood subpopulations; (iii) in silico analyses of mosaic variants using TNF receptor superfamily 1A (TNFRSF1A) crystal structure; (iv) review of the very rare TNFRSF1A mosaic variants reported previously. RESULTS: In a 36-year-old man suffering from recurrent fever for 12 years, high-depth NGS revealed a TNFRSF1A mosaic variant, c.176G>A p.(Cys59Tyr), which Sanger sequencing failed to detect. This mosaic variant displayed a variant allele fraction of 14% in whole blood; it affects both myeloid and lymphoid lineages. p.(Cys59Tyr), a recurrent germline pathogenic variant, affects a crucial cysteine located in the first cysteine-rich domain (CRD1) and involved in a disulphide bridge. Introduction of a tyrosine at this position is expected to disrupt the CRD1 structure. Review of the three previously reported TNFRSF1A mosaic variants revealed that they are all located in a small region of CRD2 and that germinal cells can be affected. CONCLUSION: This study expands the localization of TNFRSF1A mosaic variants to the CRD1 domain. Noticeably, residues involved in germline TNFRSF1A mutational hot spots can also be involved in post-zygotic mutational events. Including our study, only four patients have been thus far reported with TNFRSF1A mosaicism, highlighting the need for a high-depth NGS-based approach to avoid the misdiagnosis of TRAPS. Genetic counselling has to consider the potential occurrence of TNFRSF1A mosaic variants in germinal cells.

来源:Rheumatology (Oxford),查看原文。版权归原作者所有。

引用

  1. Assrawi E, Louvrier C, El Khouri E, et al. Mosaic variants in TNFRSF1A: an emerging cause of tumour necrosis factor receptor-associated periodic syndrome. Rheumatology (Oxford). 2022. PMID: 35640127. doi:10.1093/rheumatology/keac274

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。